NAMSA First to Receive FDA ASCA Accreditation for Medical Device Biocompatibility Testing

The ASCA Pilot Program , a first-of-its-kind conformity assessment program created by the U.S. FDA, reduces the regulatory burden on medical device manufacturers through consensus of biocompatibility testing requirements for efficiency.